Oklahoma Blood Institute (OBI) will collect convalescent plasma from donors who have recovered from COVID-19, part of an experimental initiative to use the product to treat seriously ill patients.  By creating the only statewide registry of available patients, OBI can ensure local patients receive the donated products and have the best possible chance at fighting the […]

You are unauthorized to view this page. Please Login or Subscribe